BNP Paribas Financial Markets’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-21,060
| Closed | -$24.4K | – | 5132 |
|
|
2022
Q2 | $24.4K | Buy |
21,060
+12,127
| +136% | +$12.7K | ﹤0.01% | 3676 |
|
|
2022
Q1 | $9.65K | Sell |
8,933
-12,674
| -59% | -$9.57K | ﹤0.01% | 3808 |
|
|
2021
Q4 | $15.6K | Buy |
21,607
+5,214
| +32% | +$4.22K | ﹤0.01% | 3867 |
|
|
2021
Q3 | $14.8K | Buy |
16,393
+14,159
| +634% | +$17K | ﹤0.01% | 3654 |
|
|
2021
Q2 | $3.71K | Sell |
2,234
-7,302
| -77% | -$12.2K | ﹤0.01% | 3826 |
|
|
2021
Q1 | $19.9K | Sell |
9,536
-486
| -5% | -$1.01K | ﹤0.01% | 3760 |
|
|
2020
Q4 | $12.5K | Sell |
10,022
-2,823
| -22% | -$3.37K | ﹤0.01% | 3906 |
|
|
2020
Q3 | $15.7K | Buy |
12,845
+9,590
| +295% | +$11.7K | ﹤0.01% | 3893 |
|
|
2020
Q2 | $3.81K | Sell |
3,255
-13,071
| -80% | -$12.1K | ﹤0.01% | 4097 |
|
|
2020
Q1 | $13.3K | Buy |
16,326
+8,615
| +112% | +$9.13K | ﹤0.01% | 3988 |
|
|
2019
Q4 | $7.79K | Sell |
7,711
-1,186
| -13% | -$1.44K | ﹤0.01% | 4152 |
|
|
2019
Q3 | $12.5K | Buy |
8,897
+2,527
| +40% | +$3.57K | ﹤0.01% | 4105 |
|
|
2019
Q2 | $9.55K | Sell |
6,370
-5,220
| -45% | -$8.07K | ﹤0.01% | 4108 |
|
|
2019
Q1 | $17.7K | Buy |
11,590
+10,626
| +1,102% | +$16.2K | ﹤0.01% | 3926 |
|
|
2018
Q4 | $1.42K | Sell |
964
-820
| -46% | -$1.26K | ﹤0.01% | 3869 |
|
|
2018
Q3 | $3.27K | Sell |
1,784
-1
| -0.1% | -$2 | ﹤0.01% | 4185 |
|
|
2018
Q2 | $3.28K | Buy |
+1,785
| New | +$3.32K | ﹤0.01% | 4194 |
|
|
2015
Q2 | – | Sell |
-335
| Closed | -$1.3K | – | 3659 |
|
|
2015
Q1 | $1.3K | Buy |
+335
| New | +$1.24K | ﹤0.01% | 3534 |
|
|
2014
Q4 | – | Sell |
-1,387
| Closed | -$3.69K | – | 3444 |
|
|
2014
Q3 | $3.69K | Buy |
+1,387
| New | +$9.27K | ﹤0.01% | 3879 |
|
|
2014
Q2 | – | Sell |
-17
| Closed | -$207 | – | 3994 |
|
|
2014
Q1 | $207 | Buy |
17
+12
| +240% | +$188 | ﹤0.01% | 3205 |
|
|
2013
Q4 | $89 | Buy |
+5
| New | +$81 | ﹤0.01% | 4065 |
|
BNP Paribas Financial Markets's MBII Position: Q3 2022 in Review
BNP Paribas Financial Markets sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 21,060 shares — an estimated $24.4K sold.
BNP Paribas Financial Markets first reported a position in MBII in Q4 2013 and held it in 21 quarters. The position peaked at $24.4K in Q2 2022. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.
- BNP Paribas Financial Markets reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
- BNP Paribas Financial Markets sold 21,060 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $24.4K.
- BNP Paribas Financial Markets first reported a position in Marrone Bio Innovations, Inc. in Q4 2013 and held it in 21 quarters.
- BNP Paribas Financial Markets's Marrone Bio Innovations, Inc. position peaked at $24.4K in Q2 2022.
- 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2022, filed 15 Nov 2022.